ATE522210T1 - Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung - Google Patents

Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung

Info

Publication number
ATE522210T1
ATE522210T1 AT07728341T AT07728341T ATE522210T1 AT E522210 T1 ATE522210 T1 AT E522210T1 AT 07728341 T AT07728341 T AT 07728341T AT 07728341 T AT07728341 T AT 07728341T AT E522210 T1 ATE522210 T1 AT E522210T1
Authority
AT
Austria
Prior art keywords
muscle performance
ketoglutarate
alpha
compositions
modulating muscle
Prior art date
Application number
AT07728341T
Other languages
English (en)
Inventor
Stefan Pierzynowski
Original Assignee
Sgp & Sons Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgp & Sons Ab filed Critical Sgp & Sons Ab
Application granted granted Critical
Publication of ATE522210T1 publication Critical patent/ATE522210T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
AT07728341T 2006-04-21 2007-04-20 Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung ATE522210T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL379512A PL379512A1 (pl) 2006-04-21 2006-04-21 Nowe metody i ich zastosowanie
PCT/EP2007/053882 WO2007122190A1 (en) 2006-04-21 2007-04-20 Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance

Publications (1)

Publication Number Publication Date
ATE522210T1 true ATE522210T1 (de) 2011-09-15

Family

ID=38359362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07728341T ATE522210T1 (de) 2006-04-21 2007-04-20 Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung

Country Status (10)

Country Link
US (1) US20090069429A1 (de)
EP (1) EP2020999B1 (de)
JP (1) JP2009534360A (de)
CN (1) CN101426490B (de)
AT (1) ATE522210T1 (de)
DK (1) DK2020999T3 (de)
ES (1) ES2372207T3 (de)
HK (1) HK1131340A1 (de)
PL (2) PL379512A1 (de)
WO (1) WO2007122190A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103491804A (zh) * 2011-04-18 2014-01-01 雀巢产品技术援助有限公司 具有α-HICA 和二十碳五烯酸的营养组合物
ITBO20120226A1 (it) * 2012-04-24 2013-10-25 Alfa Wassermann Spa Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
WO2016083399A1 (en) * 2014-11-24 2016-06-02 Forschungsgesellschaft Für Arbeitsphysiologie Und Arbeitsschutz E. V. Alpha-ketoglutarate in combination with glutamate dehydrogenase for treating hyperammonemia
CN106963749A (zh) * 2017-03-23 2017-07-21 华南农业大学 α‑酮戊二酸（盐）在抗疲劳和提高肌肉运动力量方面的应用
EP3856166A4 (de) 2018-09-25 2022-06-22 Ponce de Leon Health Designated Activity Company Verfahren zur herstellung von calcium-alpha-ketoglutarat
WO2020252005A1 (en) * 2019-06-10 2020-12-17 Buck Institute For Research On Aging Methods and compositions for altering senescence associated secretory phenotype

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
SE9303691D0 (sv) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
SE9402027D0 (sv) * 1994-06-10 1994-06-10 Pharmacia Ab Energy substrates
ITRM20010445A1 (it) * 2001-07-25 2003-01-27 Sigma Tau Healthscience Spa Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
MXPA05013901A (es) * 2003-07-01 2006-03-09 Essentys Ab Uso de acido alfa-cetoglutarico para tratamiento de desnutricion o condicion de glucosa alta en plasma.

Also Published As

Publication number Publication date
JP2009534360A (ja) 2009-09-24
PL2020999T3 (pl) 2012-01-31
US20090069429A1 (en) 2009-03-12
EP2020999A1 (de) 2009-02-11
CN101426490A (zh) 2009-05-06
CN101426490B (zh) 2011-01-12
EP2020999B1 (de) 2011-08-31
DK2020999T3 (da) 2011-11-21
PL379512A1 (pl) 2007-10-29
HK1131340A1 (en) 2010-01-22
ES2372207T3 (es) 2012-01-17
WO2007122190A1 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
MX2009006195A (es) Compuestos basados en 4-fenil-6-(2,2,2-trifluoro-1-feniletoxi)piri midina y metodos de su uso.
WO2007092622A3 (en) Compositions and methods for treating bone
EA201001639A1 (ru) Композиции и способы их получения и применения
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201370208A1 (ru) Формы рифаксимина и их применение
EA200971141A1 (ru) Соединения, активирующие теломеразу, и способы их применения
NO20092637L (no) Fremgangsmater for behandling
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
ATE522210T1 (de) Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung
WO2008156685A3 (en) Tendon stem cells
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
NO20076405L (no) Anvendelse av 24-nor-UDCA
EA201000392A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
MY156691A (en) 2-(r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline from 1
DE602005014632D1 (de) Pyrrol- bzw. imidazolamide zur behandlung von obesitas
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
MX2010003771A (es) Forma cristalina 2 - de 2 ((r)-2-metilpirrolidin-2-il)-1h-benzimid azol-4-carboxamida.
ATE462699T1 (de) Substituierte 4,5,6,7-tetrahydro-benzothiazol-2- ylamin-verbindungen
EA200802262A1 (ru) Назальные и буккальные композиции для борьбы с храпом
UA86051C2 (en) Substituted quinoline compounds
WO2011034896A3 (en) Small molecule inhibitors of the alpha4-paxillin interaction
UA90401C2 (ru) Средство и способ для повышения половой активности человека

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties